Fecal microbiota transplantation for recurrent C difficile infection: Ready for prime time?

被引：26

作者：

Agito, Markus D. ^{[1
]}

Atreja, Ashish ^{[2
]}

Rizk, Maged K. ^{[3
,4
]}

机构：

[1] Akron Gen Med Ctr, Dept Med, Akron, OH 44307 USA

[2] Mt Sinai Sch Med, Div Gastroenterol, New York, NY USA

[3] Cleveland Clin, Inst Digest Dis, Cleveland, OH 44106 USA

[4] Case Western Reserve Univ, Cleveland Clin, Lerner Coll Med, Cleveland, OH 44106 USA

来源：

CLEVELAND CLINIC JOURNAL OF MEDICINE | 2013年 / 80卷 / 02期

关键词：

DIARRHEA; VANCOMYCIN; BACTERIOTHERAPY; THERAPY; COLITIS; DISEASE; ANTIBIOTICS; COLONOSCOPY;

D O I：

10.3949/ccjm.80a.12110

中图分类号：

R5 [内科学];

学科分类号：

1002 ; 100201 ;

摘要：

Recurrent Clostridium difficile infection has been a major challenge for patients and clinicians. Recurrence of infection after treatment with standard antibiotics is becoming more common with the emergence of more-resistant strains of C difficile. Fecal microbiota transplantation is an alternative treatment for recurrent C difficile infection, but it is not yet widely used.

引用

页码：101 / 108

页数：8

共 49 条

[1] Recurrent Clostridium difficile colitis:: Case series involving 18 patients treated with donor stool administered via a nasogastric tube [J].